2000 George Lyman Duff memorial lecture: Atherosclerosis is a liver disease of the heart

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 6, 2001, Pages 887-898

  Davis, Roger A ^a   Hui, To Y ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Apolipoprotein B; Cholesterol 7 hydroxylase; Lipoprotein assembly secretion; Microsomal triglyceride transfer protein; Ubiquitin dependent proteasome degradation

Indexed keywords

APOLIPOPROTEIN B; BILE ACID; CELL NUCLEUS RECEPTOR; CHOLESTEROL 7ALPHA MONOOXYGENASE; OXYSTEROL; PROTEASOME; UBIQUITIN;

ANIMAL CELL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION FUNCTION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID METABOLISM; LIVER METABOLISM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; REVIEW; TRANSLATION REGULATION;

EID: 0035716449     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.6.887     Document Type: Review

References (177)

1. Cholesterol and mortality: 30 Years of follow-up from the Framingham study
2. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study
3. Long-term intraindividual cholesterol variability: Natural course and adverse impact on morbidity and mortality: The Framingham Study
4. The relationship between plasma and tissue lipids in human atherosclerosis
5. George Lyman Duff memorial lecture: Progression and regression of atherosclerotic lesions: Insights from lipid physical biochemistry
6. Role of oxidized low density lipoprotein in atherogenesis
7. Atherosclerosis: An inflammatory disease
8. Atherosclerosis
9. Atherosclerosis: Basic mechanisms: Oxidation, inflammation, and genetics
10. Apolipoprotein B: Structural and metabolic heterogeneity
11. Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits
12. Tissue sites of degradation of native and reductively methylated [14C]sucrose-labeled low density lipoprotein in rats: Contribution of receptor-dependent and receptor-independent pathways
13. Cholesterol in the prediction of atherosclerotic disease: New perspectives based on the Framingham study
14. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia
15. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain
16. A receptor-mediated pathway for cholesterol homeostasis
17. Mechanisms by which saturated triacylglycerols elevate the plasma low density lipoproteincholesterol concentration in hamsters: Differential effects of fatty acid chain length
18. Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human apoB100-overexpressing transgenic mice
19. Substrate stimulation of 7alpha-hydroxylase, an enzyme located in the cholesterol-poor endoplasmic reticulum
20. Catabolism of low density lipoproteins by perfused rabbit livers: Cholestyramine promotes receptor-dependent hepatic catabolism of low density lipoproteins
21. Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster
22. A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor
23. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes
24. Regulation of hepatic receptor-dependent degradation of LDL by mevinolin in rabbits with hypercholesterolemia induced by a wheat starch-casein diet
25. Coronary artery disease: The Scandinavian Simvastatin Survival Study experience
26. Evolution of processes and regulators of lipoprotein synthesis: From birds to mammals
27. Production of coronary arteriosclerosis with sex hormones and human chorionic gonadotropin (HCG) in juvenile steelhead and rainbow trout, Salmon gairdneri
28. Reevaluation of regression of coronary arteriosclerotic lesions in repeat-spawning steelhead trout
29. Dietary carbohydrate induces lipogenesis and very-low-density lipoprotein synthesis
30. Intrahepatic assembly of very low density lipoproteins varied synthetic response of individual apolipoproteins to fasting
31. Fasting decreases apolipoprotein B mRNA editing and the secretion of small molecular weight apoB by rat hepatocytes: Evidence that the total amount of apoB secreted is regulated post-transcriptionally
32. Intrahepatic assembly of very low density lipoproteins: Rate of transport out of the endoplasmic reticulum determines rate of secretion
33. Intrahepatic assembly of very low density lipoproteins: Immunologic characterization of apolipoprotein B in lipoproteins and hepatic membrane fractions and its intracellular distribution
34. Glucose does not stimulate apoprotein B secretion from HepG2 cells because of insufficient stimulation of triglyceride synthesis
35. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance: Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model
36. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
37. Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes
38. Oleate potentiates oxysterol inhibition of transcription from sterol regulatory element-1-regulated promoters and maturation of sterol regulatory element-binding proteins
39. Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein
40. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids: A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats
41. In non-hepatic cells, cholesterol-7α-hydroxylase induces the expression of genes regulating cholesterol biosynthesis, efflux and homeostasis
42. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta
43. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a
44. Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL
45. Coordinate regulation of lipogenesis and the assembly and secretion of apolipoprotein B-containing lipoproteins by sterol response element binding protein 1
46. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice
47. Apolipoprotein B is both integrated into and translocated across the endoplasmic reticulum membrane: Evidence for two functionally distinct pools
48. Impaired biosynthesis of phosphatidylcholine causes a decrease in the number of very low density lipoprotein particles in the Golgi but not the endoplasmic reticulum of rat liver
49. Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells
50. Influence of triacylglycerol biosynthesis rate on the assembly of apoB-100-containing lipoproteins in HepG2 cells
51. In HepG2 cells, translocation, not degradation, determines the fate of de novo synthesized apolipoprotein B
52. Studies on intracellular translocation of apolipoprotein B in a permeabilized HepG2 system
53. Biosynthesis of lipoprotein: Location of nascent apoAI and apoB in the rough endoplasmic reticulum of chicken hepatocytes
54. Determination of the intracellular distribution and pool sizes of apolipoprotein B in rabbit liver
55. Complete protein sequence and identification of structural domains of human apolipoprotein B
56. Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100
57. The complete sequence and structural analysis of human apolipoprotein B-100: Relationship between apoB-100 and apoB-48 forms
58. A signal sequence for the insertion of a transmembrane glycoprotein: Similarities to the signals of secretory proteins in primary structure and function
59. A stop-transfer sequence recognizes receptors for nascent chain translocation across the endoplasmic reticulum membrane
60. New variation on the translocation of proteins during early biogenesis of apolipoprotein B
61. Pause transfer: A topogenic sequence in apolipoprotein B mediates stopping and restarting of translocation
62. Analysis of a pause transfer sequence from apolipoprotein B
63. ApoB-100 has a pentapartite structure composed of three amphipathic alpha-helical domains alternating with two amphipathic beta-strand domains: Detection by the computer program LOCATE
64. Expression of carboxyl-terminally truncated forms of human apolipoprotein B in rat hepatoma cells: Evidence that the length of apolipoprotein B has a major effect on the buoyant density of the secreted lipoproteins
65. Carboxyl-terminal truncation of apolipoprotein B results in gradual loss of the ability to form buoyant lipoproteins in cultured human and rat liver cell lines
66. Lipoprotein Assembly: Apolipoprotein B determines lipoprotein core circumference
67. Secretion from cell culture of HDL and VLDL bearing apoB-33 with a large internal deletion
68. Rat McA-RH7777 cells efficiently assemble rat apolipoprotein B-48 or larger fragments into VLDL but not human apolipoprotein B of any size
69. Recent progress in understanding apolipoprotein B
70. The hypobetalipoproteinemias
71. Translocation of apolipoprotein B across the endoplasmic reticulum is blocked in a nonhepatic cell line
72. The endoplasmic reticulum is the site of lipoprotein assembly and regulation of secretion
73. Proteolysis-coupled secretion of the N-terminus of apolipoprotein B: Characterization of a transient, translocation arrested intermediate
74. Proteolysis and lipidfacilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells
75. Identification of two regions in apolipoprotein B100 that are exposed on the cytosolic side of the endoplasmic reticulum membrane
76. Specificity of lipid incorporation is determined by sequences in the N-terminal 37 of apoB
77. Translocation of apolipoprotein B across the endoplasmic reticulum is blocked in abetalipoproteinemia
78. Studies on the induction and biosynthesis of vitellogenin, an oestrogeninduced glycolipophosphoprotein
79. Stimulation of the synthesis of very low density lipoproteins in rooster liver by estradiol
80. Female steroid hormones and lipoprotein synthesis in the cockerel: Effects of progesterone and nafoxidine on the estrogenic stimulation of very low density lipoproteins (VLDL) synthesis
81. A triglyceride and cholesteryl ester transfer protein associated with liver microsomes
82. Purification and characterization of microsomal triglyceride and cholesteryl ester transfer protein from bovine liver microsomes
83. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia
84. Microsomal triglyceride transfer protein
85. The amino terminus of apolipoprotein B is necessary but not sufficient for microsomal triglyceride transfer protein responsiveness
86. The microsomal triglyceride transfer protein facilitates assembly and secretion of apolipoprotein B-containing lipoproteins and decreases cotranslational degradation of apolipoprotein B in transfected COS-7 cells
87. Demonstration of a physical interaction between microsomal triglyceride transfer protein and apolipoprotein B during the assembly of apoB-containing lipoproteins
88. Microsomal triacylglycerol transfer protein prevents presecretory degradation of apolipoprotein B-100: A dithiothreitolsensitive protease is involved
89. Apolipoprotein B binding to microsomal triglyceride transfer protein decreases with increases in length and lipidation: Implications in lipoprotein biosynthesis
90. The enzymatic and non-enzymatic roles of protein-disulfide isomerase in apolipoprotein B secretion
91. Folding of the amino-terminal domain of apolipoprotein B initiates microsomal triglyceride transfer protein-dependent lipid transfer to nascent very low density lipoprotein
92. Amino acids 430-570 in apolipoprotein B are critical for its binding to microsomal triglyceride transfer protein
93. Chinese hamster ovary cells require the co-expression of microsomal triglyceride transfer protein and cholesterol-7α-hydroxylase for the assembly and secretion of apolipoprotein B-containing lipoproteins
94. A common binding site on the microsomal triglyceride transfer protein for apolipoprotein B and protein disulfide isomerase
95. Identification of domains in apolipoprotein B100 that confer a high requirement for the microsomal triglyceride transfer protein
96. Inhibition of the microsomal triglyceride transfer protein blocks the first step of apolipoprotein B lipoprotein assembly but not the addition of bulk core lipids in the second step
97. Co-translational degradation of apolipoprotein B100 by the proteasome is prevented by microsomal triglyceride transfer protein: Synchronized translation studies on HepG2 cells treated with an inhibitor of microsomal triglyceride transfer protein
98. Microsomal triglyceride transfer protein, the abetalipoproteinemia gene product, mediates the secretion of apolipoprotein B-containing lipoproteins from heterologous cells
99. Secretion of apolipoprotein B-containing lipoproteins from HeLa Cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability
100. Murine mammary-derived cells secrete the N-terminal 41% of human apolipoprotein B on high density lipoprotein-sized lipoproteins containing a triacylglycerol-rich core
101. In vitro reconstitution of assembly of apolipoprotein B48-containing lipoproteins
102. Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma: Indication for an assembly defect
103. An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells
104. Normal activity of microsomal triglyceride transfer protein is required for the oleate-induced secretion of very low density lipoproteins containing apolipoprotein B from McA-RH7777 cells
105. Evidence that microsomal triglyceride transfer protein is limiting in the production of apolipoprotein B-containing lipoproteins in hepatic cells
106. Knockout of the abetalipoproteinemia gene in mice: Reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes
107. A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion
108. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B
109. Decreased secretion of ApoB follows inhibition of ApoB-MTP binding by a novel antagonist
110. Translocation efficiency, susceptibility to proteasomal degradation, and lipid responsiveness of apolipoprotein B are determined by the presence of beta sheet domains
111. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice
112. Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein/low density lipoprotein production in a viable conditional knockout mouse
113. Protein degradation in the endoplasmic reticulum
114. Quality control in the secretory pathway
115. A novel mechanism for regulating activity of a transcription factor that controls the unfolded protein response
116. ER quality control: The cytoplasmic connection
117. Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans
118. Inhibition of proteasome activities and subunit-specific aminoterminal threonine modification by lactacystin
119. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B
120. The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70
121. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum
122. Calnexin and other factors that alter translocation affect the rapid binding of ubiquitin to apoB in the Sec61 complex
123. Translocation-arrested apolipoprotein B evades proteasome degradation via a sterol-sensitive block in ubiquitin conjugation
124. Studies on degradative mechanisms mediating post-translational fragmentation of apolipoprotein B and the generation of the 70-kDa fragment
125. Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes
126. Intracellular degradation of newly synthesized apolipoprotein B
127. The assembly and secretion of apolipoprotein B-containing lipoproteins
128. Apolipoprotein B: mRNA editing, lipoprotein assembly, and presecretory degradation
129. Efficient glycosylation site utilization by intracellular apolipoprotein B: Implications for proteasomal degradation
130. The amino-terminal domain of apolipoprotein B does not undergo retrograde translocation from the endoplasmic reticulum to the cytosol: Proteasomal degradation of nascent apolipoprotein B begins at the carboxyl terminus of the protein, while apolipoprotein is still in its original translocon
131. Co-translational interactions of apoprotein B with the ribosome and translocon during lipoprotein assembly or targeting to the proteasome
132. Apoprotein B100 has a prolonged interaction with the translocon during which its lipidation and translocation change from dependence on the microsomal triglyceride transfer protein to independence
133. Growth and differentiation of cytoplasmic membranes in the course of lipoprotein granule synthesis in the hepatic cell, I: Elaboration of elements of the Golgi complex
134. Golgi fractions prepared from rat liver homogenates, I: Isolation procedure and morphological characterization
135. Subcellular localization of B apoprotein of plasma lipoproteins in rat liver
136. Chylomicron-sized lipid particles are formed in the setting of apolipoprotein B deficiency
137. Nascent VLDL assembly occurs in two steps in the endoplasmic reticulum (ER) of hepatocytes
138. Assembly of very low density lipoprotein: A two-step process of apolipoprotein B core lipidation
139. The assembly and secretion of apolipoprotein B-48-containing very low density lipoproteins in McA-RH7777 cells
140. ADP-ribosylation factor 1 and its activation of phospholipase D are important for the assembly of very low density lipoproteins
141. Brefeldin A reversibly inhibits the assembly of apoB containing lipoproteins in McA-RH7777 cells
142. The assembly of very low density lipoproteins in rat hepatoma McA-RH7777 cells is inhibited by phospholipase A2 antagonists
143. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase I
144. Transcriptional activation of the stearoyl-CoA desaturase 2 gene by sterol regulatory element-binding protein/adipocyte determination and differentiation factor 1
145. Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2
146. Isoprenoids, sterols and bile acids
147. Nature of the metabolic products of 14C-cholesterol excreted in bile and feces
148. Disruption of cholesterol 7α-hydroxylase gene in mice, I: Postnatal lethality reversed by bile acid and vitamin supplementation
149. Disruption of cholesterol 7 a-hydroxylase gene in mice, II: Bile acid deficiency is overcome by induction of oxysterol 7α-hydroxylase
150. Apolipoprotein B synthesis in rat small intestine: Regulation by dietary triglyceride and biliary lipid
151. Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2)
152. Point mutations in the ileal bile salt transporter cause leaks in the enterohepatic circulation leading to severe chronic diarrhea and malabsorption
153. The role of oxidized LDL in the atherogenic process
154. The Yin and Yang of oxidation in the development of the fatty streak: A review based on the 1994 George Lyman Duff Memorial Lecture
155. Low density lipoprotein oxidation and its pathobiological significance
156. Regulation of hepatic lipoprotein receptors in the dog: Rapid regulation of apolipoprotein B, E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids
157. Expression of 7-alpha-hydroxylase in non-hepatic cells results in liver phenotypic resistance of the low density lipoprotein receptor to cholesterol repression
158. 7-Alpha hydroxylation of 25-hydroxycholesterol in liver microsomes: Evidence that the enzyme involved is different from cholesterol 7-alpha-hydroxylase
159. Oxysterol 7alpha-hydroxylase activity by cholesterol 7alpha-hydroxylase (CYP7A)
160. 24-Hydroxycholesterol is a substrate for hepatic cholesterol 7alpha-hydroxylase (CYP7A)
161. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter, I: Identification of the protein and delineation of its target nucleotide sequence
162. Bile acid kinetics in relation to endogenous triglyceride metabolism in various types of hyperlipoproteinemia
163. Bile acid metabolism in hereditary forms of hypertriglyceridemia: Evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia
164. Measurement of bile acid synthesis by three different methods in hypertriglyceridemic and control subjects
165. Diminished gene expression of ileal apical sodium bile acid transporter explains impaired absorption of bile acid in patients with hypertriglyceridemia
166. Abnormal bile acid absorption in familial hypertriglyceridemia
167. Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides
168. The hypotriglyceridemic effect of chenodeoxycholic acid in type IV hyperlipemia
169. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway
170. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta
171. Nuclear orphan receptors control cholesterol catabolism
172. Bile acids: Natural ligands for an orphan nuclear receptor
173. Identification of a nuclear receptor for bile acids
174. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
175. Don't know much bile-ology
176. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR
177. Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands